IP
EXAS

Isthmus Partners’s Exact Sciences EXAS Stock Holding History

Isthmus Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,313
Closed -$1.25M – 221
2025
Q4 		$1.25M Buy
12,313
+86
+0.7% +$6.91K 0.14% 116
2025
Q3 		$669 Hold
12,227
– – ﹤0.01% 172
2025
Q2 		$650K Hold
12,227
– – 0.08% 132
2025
Q1 		$529K Hold
12,227
– – 0.07% 138
2024
Q4 		$687K Buy
12,227
+1,000
+9% +$62.2K 0.08% 125
2024
Q3 		$765K Hold
11,227
– – 0.09% 118
2024
Q2 		$474K Sell
11,227
-1,000
-8% -$55K 0.06% 137
2024
Q1 		$844K Sell
12,227
-2,006
-14% -$127K 0.1% 119
2023
Q4 		$1.05M Hold
14,233
– – 0.14% 115
2023
Q3 		$971K Buy
14,233
+2,027
+17% +$172K 0.14% 115
2023
Q2 		$1.15M Buy
12,206
+6
+0% +$468 0.16% 110
2023
Q1 		$827K Buy
12,200
+1,000
+9% +$64.3K 0.12% 117
2022
Q4 		$555K Hold
11,200
– – 0.08% 127
2022
Q3 		$364K Buy
11,200
+1,615
+17% +$66.6K 0.06% 133
2022
Q2 		$378K Buy
9,585
+1,000
+12% +$53.5K 0.07% 123
2022
Q1 		$600K Hold
8,585
– – 0.1% 121
2021
Q4 		$668K Buy
8,585
+2,000
+30% +$177K 0.11% 123
2021
Q3 		$629K Hold
6,585
– – 0.11% 123
2021
Q2 		$819K Hold
6,585
– – 0.14% 115
2021
Q1 		$868K Hold
6,585
– – 0.16% 110
2020
Q4 		$872K Hold
6,585
– – 0.18% 105
2020
Q3 		$671K Hold
6,585
– – 0.16% 104
2020
Q2 		$572K Hold
6,585
– – 0.14% 109
2020
Q1 		$382K Hold
6,585
– – 0.12% 109
2019
Q4 		$609K Hold
6,585
– – 0.14% 107
2019
Q3 		$595K Hold
6,585
– – 0.14% 106
2019
Q2 		$777K Sell
6,585
-24,421
-79% -$2.46M 0.19% 101
2019
Q1 		$1.79M Buy
31,006
+24,421
+371% +$2.08M 0.44% 47
2018
Q4 		$416K Hold
6,585
– – 0.13% 112
2018
Q3 		$520K Hold
6,585
– – 0.13% 106
2018
Q2 		$394K Sell
6,585
-2,000
-23% -$108K 0.1% 114
2018
Q1 		$346K Sell
8,585
-5,000
-37% -$244K 0.09% 114
2017
Q4 		$714K Sell
13,585
-2,465
-15% -$132K 0.19% 93
2017
Q3 		$756K Hold
16,050
– – 0.21% 92
2017
Q2 		$568K Sell
16,050
-150
-0.9% -$4.63K 0.17% 100
2017
Q1 		$383K Hold
16,200
– – 0.11% 113
2016
Q4 		$216K Hold
16,200
– – 0.07% 128
2016
Q3 		$299K Hold
16,200
– – 0.09% 116
2016
Q2 		$198K Buy
16,200
+5,000
+45% +$37.7K 0.07% 126
2016
Q1 		$75K Hold
11,200
– – 0.03% 160
2015
Q4 		$103K Buy
11,200
+6,200
+124% +$57.6K 0.04% 148
2015
Q3 		$90K Hold
5,000
– – 0.03% 153
2015
Q2 		$149K Hold
5,000
– – 0.05% 139
2015
Q1 		$110K Buy
5,000
+1,000
+25% +$25.4K 0.04% 147
2014
Q4 		$110K Buy
+4,000
New +$97.3K 0.04% 149

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Isthmus Partners's EXAS Position: Q1 2026 in Review

Isthmus Partners sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 12,313 shares — an estimated $1.25M sold.

Isthmus Partners first reported a position in EXAS in Q4 2014 and held it in 45 quarters. The position peaked at $1.79M in Q1 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Isthmus Partners reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Isthmus Partners sold 12,313 Exact Sciences shares in Q1 2026, an estimated $1.25M.
  • Isthmus Partners first reported a position in Exact Sciences in Q4 2014 and held it in 45 quarters.
  • Isthmus Partners's Exact Sciences position peaked at $1.79M in Q1 2019.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Isthmus Partners's 13F filing for Q1 2026, filed 30 Apr 2026.